Management of sarcoidosis

Taking place on 7 June, this ERS Vision Live panel discussion focused on the management of sarcoidosis.

The expert panellists discussed key areas, including:

  • Difficult issues in the management of cardiac sarcoidosis,
  • who should be treated in sarcoidosis: risk stratification and quality of life issues,
  • and finally, treatment regimens in sarcoidosis: what to choose and related issues.

Chairs

Prof. Athol Wells 

  • Athol Wells trained in New Zealand before moving to the Brompton Hospital initially as a research fellow before taking up his current post 23 years ago as a clinician leading in ILD.   
  • He has broad ILD research interests covering clinical science (including diagnosis and prognostic evaluation) and translational research.   
  • He has over 530 publications on Medline and is a member of the Fleischner Society and president Elect of the World Association of Sarcoidosis     

Prof. Elisabeth Renzoni 

  • Elizabeth Renzoni is an ILD specialist working at the Brompton Hospital.  
  • Her key clinical interests include sarcoidosis, idiopathic and connective tissue disease associated ILD, hypersensitivity pneumonitis. Her key research interests include prognostic and outcome biomarkers in lung fibrosis across ILD entities. 
  • She has participated in several recent clinical practice guidelines and is an Associate Editor for Respirology.   

Speakers

Dr. Vasilis Kouranis 

  • Vasilis Kouranos is a consultant respiratory physician at the Royal Brompton Hospital and honorary senior lecturer at Imperial College, London. 
  • He is actively involved in clinical research and part of his research activities he has co-designed and participated as principal investigator in clinical trials in treatment of pulmonary and cardiac sarcoidosis. 
  • He has great experience in management of patients with sarcoidosis, interstitial lung disease and pulmonary fibrosis. 

Dr. Marlies Wijseenbeek 

  • Marlies Wijsenbeek is chair of the Erasmus MC multidisciplinary Centre of Interstitial Lung Diseases and Sarcoidosis (ILDS); a national expert centre and member of the European Reference Network based at the Erasmus University Medical Centre, Netherlands.   
  • Her research interests include patient-centred outcome measures in ILDS, e-health, and new therapies in pulmonary fibrosis and sarcoidosis.  
  • She is chair of the ERS Group 12.01 and associate editor of the European Respiratory Journal  

Dr. Dominique Valeyre 

  • Dominique Valeyre is Professor emeritus of Pulmonology in the University Paris Sorbonne Nord and a pulmonologist in the Hôpital Saint Joseph, in Paris, France. 
  • He is involved in research on sarcoidosis and interstitial lung disease and was the co-chair of the recent ERS-TF clinical practice guidelines on treatment of sarcoidosis. 

Management of sarcoidosis

ERS Vision